Recombinant Human Carbonic Anhydrase VII Protein, CF

R&D Systems | Catalog # 3177-CA

R&D Systems
Loading...

Key Product Details

  • R&D Systems E. coli-derived Recombinant Human Carbonic Anhydrase VII Protein (3177-CA)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

E. coli

Accession Number

Applications

Enzyme Activity
Loading...

Product Specifications

Source

E. coli-derived human Carbonic Anhydrase VII/CA7 protein
Thr2-Ala264, with a C-terminal 10-His tag

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Thr2

Predicted Molecular Mass

31 kDa

SDS-PAGE

31 kDa, reducing conditions

Activity

Measured by its esterase activity.
The specific activity is >20 pmol/min/µg, as measured under the described conditions.

Formulation, Preparation, and Storage

3177-CA
Formulation Supplied as a 0.2 μm filtered solution in Tris and NaCl.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: Carbonic Anhydrase VII/CA7

Carbonic anhydrase catalyzes the reversible reaction of CO2 + H2O = HCO3- + H+, which is fundamental to many processes such as respiration, renal tubular acidification and bone resorption (2). Topics in a CA meeting (6th International Conference on the CAs, June 20-25, 2003, Slovakia) ranged from the use of CAs as markers for tumor and hypoxia in the clinic, as a nutritional supplement in milk, and as a tool for CO2 removal and mosquito control in industry. Carbonic Anhydrase VII encoded by the CA7 gene is a cytosolic protein predominantly expressed in the salivary gland (1). CA7 may have additional tissue distributions and functions. For example, studies with CA inhibitors provide evidence that human CA7 is the CA isozyme responsible for the anticonvulsant/antiepileptic activity of sulfonamides and sulfamates (3). In fact, CA7 has been shown in a rat model to act as a developmental switch in GABAergic signaling in neurons (4, 5). The amino acid sequence of human CA7 is 95%, 94%, 89%, 76%, 72% and 70% identical to that of bovine, rat/mouse, canine, chicken, Xenopus, and zebrafish.

References

  1. Montgomery, J.C. et al. (1991) Genomics 11:835.
  2. Hewett-Emmett, D. and R.E. Tashian (1996) Mol. Phylogenet. Evol. 5:50.
  3. Vullo, D. et al. (2005) Bioorg. Med. Chem. Lett. 15:971.
  4. Ruusuvuori, E. et al. (2004) J. Neurosci. 24:2699.
  5. Rivera, C. et al. (2005) J. Physiol. 562:27.

Alternate Names

CA7

Entrez Gene IDs

766 (Human)

Gene Symbol

CA7

UniProt

Additional Carbonic Anhydrase VII/CA7 Products

Product Documents for Recombinant Human Carbonic Anhydrase VII Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human Carbonic Anhydrase VII Protein, CF

For research use only

Customer Reviews for Recombinant Human Carbonic Anhydrase VII Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Carbonic Anhydrase VII Protein, CF and earn rewards!

Have you used Recombinant Human Carbonic Anhydrase VII Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human Carbonic Anhydrase VII Protein, CF (3177-CA):

Materials
  • Assay Buffer: 12.5 mM Tris, 75 mM NaCl, pH 7.5
  • Recombinant Human Carbonic Anhydrase VII/CA7 (rhCA7) (Catalog # 3177-CA)
  • Substrate: 4-Nitrophenyl Acetate (4-NPA) (Sigma, Catalog # N8130), 100 mM stock in acetone
  • 96-well Clear Plate (Costar, Catalog # 92592)
  • Plate reader (Model: SpectraMax Plus by Molecular Devices) or equivalent
  1. Dilute rhCA7 to 40 ng/µL in Assay Buffer.
  2. Dilute Substrate to 2 mM in Assay Buffer.
  3. Load in plate, 50 µL of 50 ng/µL rhCA7, and start the reaction by adding 50 µL of 2 mM Substrate. Include a Substrate Blank containing 50 µL Assay Buffer and 50 µL of 2 mM Substrate.
  4. Read at a wavelength of 400 nm (bottom read) in kinetic mode for 5 minutes.
  5. Calculate specific activity:

     Specific Activity (pmol/min/µg) =

Adjusted Vmax* (OD/min) x Conversion Factor** (pmol/OD)
amount of enzyme (µg)

     *Adjusted for Substrate Blank
     **Derived using calibration standard 4-Nitrophenol (Sigma, Catalog # 241326).

Per Well:
  • rhCA7: 2 µg
  • Substrate: 1 mM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes
Loading...